- Home
- SGHC vs RNA Comparison
SGHC vs RNA Comparison
Compare SGHC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHC
- RNA
- Stock Information
- Founded
- SGHC 2020
- RNA 2012
- Country
- SGHC Guernsey
- RNA United States
- Employees
- SGHC N/A
- RNA N/A
- Industry
- SGHC Services-Misc. Amusement & Recreation
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- SGHC Consumer Discretionary
- RNA Health Care
- Exchange
- SGHC Nasdaq
- RNA Nasdaq
- Market Cap
- SGHC 3.6B
- RNA 3.7B
- IPO Year
- SGHC N/A
- RNA 2020
- Fundamental
- Price
- SGHC $6.62
- RNA $31.60
- Analyst Decision
- SGHC Strong Buy
- RNA Strong Buy
- Analyst Count
- SGHC 5
- RNA 12
- Target Price
- SGHC $10.40
- RNA $68.25
- AVG Volume (30 Days)
- SGHC 892.3K
- RNA 1.3M
- Earning Date
- SGHC 05-07-2025
- RNA 05-08-2025
- Dividend Yield
- SGHC 4.38%
- RNA N/A
- EPS Growth
- SGHC N/A
- RNA N/A
- EPS
- SGHC 0.01
- RNA N/A
- Revenue
- SGHC $1,736,303,814.00
- RNA $10,897,000.00
- Revenue This Year
- SGHC $18.72
- RNA N/A
- Revenue Next Year
- SGHC $11.20
- RNA $230.08
- P/E Ratio
- SGHC $735.06
- RNA N/A
- Revenue Growth
- SGHC 10.78
- RNA 13.98
- 52 Week Low
- SGHC $2.90
- RNA $21.56
- 52 Week High
- SGHC $8.51
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- SGHC 39.71
- RNA 50.31
- Support Level
- SGHC $6.75
- RNA $30.12
- Resistance Level
- SGHC $7.11
- RNA $33.13
- Average True Range (ATR)
- SGHC 0.26
- RNA 2.14
- MACD
- SGHC 0.00
- RNA 0.14
- Stochastic Oscillator
- SGHC 28.26
- RNA 35.92
About SGHC Super Group (SGHC) Limited
Super Group (SGHC) Ltd is a holding company that operates global online sports betting and gaming businesses. The company has two reportable segments, namely Betway and Spin. The majority of the company's revenue comes from the Betway segment, which is a single-brand online sportsbook business with a global reach. Betway has formed strategic partnerships with teams and leagues across the world and recovers sponsorship marketing spend through brand license agreements. The Betway segment generates the majority of the company's revenue.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.